Waldenström macroglobulinemia (WM) is a rare disorder. In the US in 2016, there were an estimated 1270 new cases of WM.[5]Teras LR, DeSantis CE, Cerhan JR, et al. 2016 US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J Clin. 2016 Nov 12;66(6):443-59.
https://acsjournals.onlinelibrary.wiley.com/doi/full/10.3322/caac.21357
http://www.ncbi.nlm.nih.gov/pubmed/27618563?tool=bestpractice.com
WM most commonly occurs in older white men (ages >70 years).[6]Yin X, Chen L, Fan F, et al. Trends in incidence and mortality of Waldenström macroglobulinemia: a population-based study. Front Oncol. 2020 Sep 10;10:1712.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511580
http://www.ncbi.nlm.nih.gov/pubmed/33014849?tool=bestpractice.com
[7]Wang H, Chen Y, Li F, et al. Temporal and geographic variations of Waldenstrom macroglobulinemia incidence: a large population-based study. Cancer. 2012 Aug 1;118(15):3793-800.
https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.26627
http://www.ncbi.nlm.nih.gov/pubmed/22139816?tool=bestpractice.com
[8]Groves FD, Travis LB, Devesa SS, et al. Waldenstrom's macroglobulinemia: incidence patterns in the United States, 1988-1994. Cancer. 1998 Mar 15;82(6):1078-81.
http://www.ncbi.nlm.nih.gov/pubmed/9506352?tool=bestpractice.com
[9]Herrinton LJ, Weiss NS. Incidence of Waldenstrom's macroglobulinemia. Blood. 1993 Nov 15;82(10):3148-50.
http://bloodjournal.org/content/82/10/3148.full.pdf+html
http://www.ncbi.nlm.nih.gov/pubmed/8219203?tool=bestpractice.com
[10]Phekoo KJ, Jack RH, Davies E, et al. The incidence and survival of Waldenstrom's macroglobulinaemia in South East England. Leuk Res. 2008 Jan;32(1):55-9.
http://www.ncbi.nlm.nih.gov/pubmed/17416416?tool=bestpractice.com
In one US study using Surveillance Epidemiology and End Results (SEER) data (1980-2016), an age-adjusted annual incidence rate of 0.48 per 100,000 was reported.[6]Yin X, Chen L, Fan F, et al. Trends in incidence and mortality of Waldenström macroglobulinemia: a population-based study. Front Oncol. 2020 Sep 10;10:1712.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511580
http://www.ncbi.nlm.nih.gov/pubmed/33014849?tool=bestpractice.com
WM annual incidence increased with age, from 0.06 per 100,000 in those ages under 50 years to 3.2 per 100,000 in those ages 80 years and over.[6]Yin X, Chen L, Fan F, et al. Trends in incidence and mortality of Waldenström macroglobulinemia: a population-based study. Front Oncol. 2020 Sep 10;10:1712.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511580
http://www.ncbi.nlm.nih.gov/pubmed/33014849?tool=bestpractice.com
WM incidence was higher in men than women (0.65 per 100,000 vs. 0.36 per 100,000, respectively) and in white people than black people (0.52 per 100,000 vs. 0.29 per 100,000, respectively).[6]Yin X, Chen L, Fan F, et al. Trends in incidence and mortality of Waldenström macroglobulinemia: a population-based study. Front Oncol. 2020 Sep 10;10:1712.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511580
http://www.ncbi.nlm.nih.gov/pubmed/33014849?tool=bestpractice.com
In the US, median age at diagnosis is 73 years.[7]Wang H, Chen Y, Li F, et al. Temporal and geographic variations of Waldenstrom macroglobulinemia incidence: a large population-based study. Cancer. 2012 Aug 1;118(15):3793-800.
https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.26627
http://www.ncbi.nlm.nih.gov/pubmed/22139816?tool=bestpractice.com
In one UK study using registry data from 1999 to 2001, the age-adjusted annual incidence rate of WM was 0.55 per 100,000.[10]Phekoo KJ, Jack RH, Davies E, et al. The incidence and survival of Waldenstrom's macroglobulinaemia in South East England. Leuk Res. 2008 Jan;32(1):55-9.
http://www.ncbi.nlm.nih.gov/pubmed/17416416?tool=bestpractice.com
Annual incidence increased with age and was higher in men than women (0.73 per 100,000 vs. 0.42 per 100,000, respectively). Median age at diagnosis was 75 years.[10]Phekoo KJ, Jack RH, Davies E, et al. The incidence and survival of Waldenstrom's macroglobulinaemia in South East England. Leuk Res. 2008 Jan;32(1):55-9.
http://www.ncbi.nlm.nih.gov/pubmed/17416416?tool=bestpractice.com